Aillis

About Aillis

Aillis, Inc. aims to shape the future of healthcare by empowering all for co-creation. Their mission is to create an open and collaborative medical environment, challenging the status quo to build a transparent and accessible healthcare system.

Products & Services

AI Medical Device for COVID-19 Detection:An AI-powered medical device that uses throat images to diagnose COVID-19, recently approved for pharmaceutical use in Japan.

Specialties

AI Medical Devices Digital Healthcare Medical Technology Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment Prize T: - FT: Investment Prize	A: 1000000 MR: - FA: $1 Million FAN: 1000000	D: 2023-12-07 FD: 2023-12-07	1 investors

Investment Prize Latest

2023-12-07

$1.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

O

OKIYAMA Sho

Representative Director and President

K

KATO Hiroaki

Director and Vice President

F

FUKUDA Atsushi

Director

N

NAKAMURA Mio

Director

H

HIURA Toshihiko

Outside Director

I

ITO Tsuyoshi

Outside Director

View 44 more team members with Pro

Unlock Full Team Directory

Recent News

Aillis Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised